DIPROSONE Cream - betamethasone dipropionate

Diprosone Cream

Each gram contains betamethasone dipropionate equivalent to 0.5 mg of betamethasone

Company Name

Memphis/Schering

Therapeutic Group

TOP CORTICOSTEROIDS PLAIN

Pharmaceutical form
Cream

Package

Tubes of 10 grams

Diprosone Cream Indications

DIPROSONE Cream are indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Diprosone Cream Warning & Precautions

If irritation or sensitization develops with the use of DIPROSONE Cream , treatment should be discontinued and appropriate therapy instituted. In the presence of an infection, an appropriate antifungal or antibacterial agent should be administered. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been controlled adequately. Any of the side effects that are reported following systemic use of corticosteroids, including adrenal suppression, may also occur with topical corticosteroids, especially in infants and children. Systemic absorption of topical corticosteroids will be increased if extensive skin surfaces are treated or if occlusive technique is used. Suitable precautions should be taken under these conditions or when long-term use is anticipated, particularly in infants and children. DIPROSONE Cream and Ointment are not for ophthalmic use. Pediatric Use: Pediatric patients may demonstrate greater susceptibility than mature patients to topical corticosteroid¬induced HPA axis suppression and to exogenous corticosteroid effects because of greater absorption due to a larger skin surface area to body weight ratio. HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include a bulging fontanelle, headaches and bilateral papilledema. USE DURING PREGNANCY AND IN NURSING WOMEN: Since safety of topical corticosteroid use in pregnant women has not been established, drugs of this class should be used during pregnancy only if the potential benefit Justifies the potential risk to the fetus. Drugs of this class should not be used extensively in large amounts or for prolonged periods of time in pregnant patients. Since it is not known whether topical administration of corticosteroids can result in sufficient systemic absorption to produce detectable quantities in breast milk, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Product Type
Human

Diprosone Cream Dosage

A thin film of DIPROSONE Cream should be applied to cover completely the affected area once or twice daily, morning and night.

Diprosone Cream Adverse Reactions

The following local adverse reactions have been infrequently reported with the use of topical corticosteroids especially under occlusive dressings: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria

Diprosone Cream Contraindications

DIPROSONE Cream are contraindicated in those patients with a history of sensitivity reactions to any of its components.

Drug Interactions

NA

Search Post

Label :